Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
A Risk Prediction Modeling Based on SEM Chenchen He Southwest University, China NLST Mar 10, 2016 NLST-199
A Risk Prediction Modeling Based on SEM Chenchen He Southwest University, China PLCO Mar 18, 2016 PLCO-198
A RISK-STRATIFIED APPROACH TO PROSTATE CANCER SCREENING IN THE PROSTATE, LUNG, COLORECTAL AND OVARIAN TRIAL PARTICIPANTS Firas Abdollah Henry Ford Hospital PLCO Aug 31, 2016 PLCO-226
Artificial Intelligence based biomarkers for breast cancer Nameeta Shah Amaranth Medical Analytics PLCO Oct 31, 2023 PLCOI-1375
Artificial Intelligence -based Computer Aided Early Diagnosis for low dose CT scans Jolu Ninan Abu Dhabi University NLST Nov 19, 2018 NLST-450
Artificial Intelligence Based Detection and Radiomics Analysis of Lung Nodules from Lung Screening CT Yin-Hung Lin Taiwan AI Labs NLST Sep 4, 2018 NLST-441
Artificial Intelligence-Based Pathological Model for Predicting Biochemical Recurrence in Prostate Cancer: a Multicenter Study Rui Chen Shanghai Jiao Tong University School of Medicine PLCO Feb 26, 2024 PLCOI-1486
Artificial intelligence for detection of obstructive airway disease and malignant pulmonary nodules Majid Afshar Loyola University Medical Center NLST Jun 24, 2019 NLST-520
Artificial Intelligence in Oncology Scott Johnson Varian NLST Apr 9, 2018 NLST-399
Artificial Intelligence to detect and classify tumors Daniel Meyer Sphera, Inc. NLST May 12, 2016 NLST-215
Artificial Intelligence To Predict The Risk Of Malignancy In Lung Cancer By Low-Dose CT Screening Studies Christian Salvatore DeepTrace Technologies, spin-off of University School for Advanced Studies IUSS Pavia NLST Dec 21, 2020 NLST-739
Artificial Neural Network Analysis of NLST Data for determining clusters of patient factors and CT lesion features most predictive of true positives and true negatives, false positives and false negatives John Weaver HealthView Preventive Medical Center NLST Jul 25, 2013 NLST-27
ARTIFICIAL STAINING OF HISTOPATHALOGICAL IMAGES Alper Yilmaz The Ohio State University NLST May 31, 2019 NLST-516
Arylamine hemoglobin (Hgb)-adducts and bladder cancer risk in never-smokers within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) Jonine Figueroa NCI PLCO Nov 22, 2010 2010-0113
A semi-supervised deep clustering framework for personalized post-test risk-stratification in lung cancer screening Stefano Diciotti Department of Electrical, Electronic, and Information Engineering "Guglielmo Marconi" (DEI), Alma Mater Studiorum - University of Bologna NLST Aug 2, 2022 NLST-942
A Shared Artificial Intelligence Cancer Treatment Recommender System Nezamoddin Nezamoddini-Kachouie Florida Institute of Technology PLCO Jul 24, 2024 PLCO-1633
A Simple System for the Early Detection of Breast Cancer Stephen Albert Johnston Arizona State University PLCO Apr 4, 2014 2014-0002
A simulation modeling study examining the downstream effects of follow-up schedules for screen-detected nodules Chung Yin (Joey) Kong Massachusetts General Hospital / Harvard Medical School NLST Sep 28, 2017 NLST-357
A simulation modeling study examining the downstream effects of follow-up schedules for screen-detected nodules Chung Yin (Joey) Kong Massachusetts General Hospital PLCO Nov 27, 2017 PLCO-317
Aspirin use and risk of hepatocellular carcinoma incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Holli Loomans-Kropp National Cancer Institute PLCO Mar 18, 2020 PLCO-601